10-K/A: Village Farms International Files Amended 10-K, Restates Financials and Addresses Internal Control Weakness

Sentiment:

Annual Results Amendment


Village Farms International filed an amended 10-K report to restate its financials and address a material weakness in internal controls related to goodwill and intangible asset valuations.

Worse than expectedThe company reported a net loss of $31.798 million, which is worse than the previous year's loss of $101.146 million.The company recorded a $11.3 million impairment charge to goodwill for its Cannabis U.S. reporting unit, indicating a decline in asset value.The identification of a material weakness in internal control over financial reporting is a negative development.

Summary

  • Village Farms International has filed an amendment to its annual report on Form 10-K for the year ended December 31, 2023.
  • The amendment includes a restated report from the independent auditor and updated certifications from the CEO and CFO.
  • The company identified a material weakness in its internal control over financial reporting related to the valuation of goodwill and intangible assets.
  • This weakness was due to errors in a key spreadsheet used for calculations, which management is working to remediate by involving third-party valuation specialists.
  • The company's management concluded that, as of December 31, 2023, the fair value of the Cannabis U.S. reporting unit was lower than its carrying amount, resulting in an impairment charge to goodwill of $11.3 million.
  • The fair value of the Cannabis Canada reporting unit was determined to be higher than its carrying amount, requiring no impairment to goodwill.
  • The company's total assets were $466.989 million as of December 31, 2023, compared to $465.285 million in 2022.
  • The company reported a net loss attributable to Village Farms International, Inc. shareholders of $31.798 million for 2023, compared to a loss of $101.146 million in 2022.

Sentiment

Score: 3

Explanation: The document reveals significant issues including a material weakness in internal controls and a substantial goodwill impairment, which are major concerns for investors. While the company is taking steps to address these issues, the overall tone is negative due to the financial losses and control deficiencies.

Positives

  • The company is actively addressing the identified material weakness in internal controls by involving third-party valuation specialists.
  • The company's management is committed to enhancing the precision of its financial controls.
  • The Cannabis Canada reporting unit did not require any impairment to goodwill, indicating a stable valuation.

Negatives

  • The company identified a material weakness in its internal control over financial reporting.
  • The company recorded a significant impairment charge of $11.3 million to goodwill for its Cannabis U.S. reporting unit.
  • The company reported a net loss of $31.798 million for 2023.

Risks

  • The material weakness in internal control over financial reporting could lead to future misstatements in financial reports.
  • The impairment of goodwill in the Cannabis U.S. segment indicates potential challenges in that market.
  • The company's ongoing losses could impact its financial stability and future growth.

Future Outlook

The company is focused on remediating the material weakness in internal controls and enhancing the precision of its financial reporting. Management will continue to enhance the precision of this control including involving third party valuation specialists in order to remediate the material weakness. The material weakness will be fully remediated when, in the opinion of the company's management, the revised control procedures are appropriately operated for a sufficient period of time to provide reasonable assurance as to their effectiveness.

Management Comments

  • Management concluded that, as of December 31, 2023, the fair value of the Cannabis U.S. reporting unit was lower than its carrying amount, resulting in an impairment charge to goodwill of $11.3 million.
  • Management concluded that the fair value of the Cannabis Canada reporting unit was higher than its carrying amount as of December 31, 2023 and therefore no impairment to goodwill was required.
  • Management is responsible for establishing and maintaining adequate internal control over financial reporting.

Industry Context

The cannabis industry is facing regulatory uncertainty and market volatility, which is reflected in the impairment of goodwill in the U.S. cannabis segment. The company's focus on both produce and cannabis provides some diversification, but the challenges in the cannabis sector are impacting overall financial performance.

Comparison to Industry Standards

  • The impairment of goodwill in the Cannabis U.S. segment is not uncommon in the current market, as many cannabis companies are facing similar valuation challenges due to regulatory uncertainty and market saturation.
  • The company's internal control weakness is a concern, as it indicates a potential lack of robustness in financial reporting processes, which is not ideal compared to industry best practices.
  • The company's financial performance, with a net loss of $31.798 million, is not unusual for companies in the cannabis sector, which are often in a growth phase and may not be profitable yet.
  • Compared to other agricultural companies, Village Farms' diversification into cannabis adds a layer of complexity and risk, which is reflected in the financial results.

Related Party Transactions

  • The company leases its Rose office building from a company employee who also owns a minority interest in Rose.
  • One of the company's employees is related to a member of the company's executive management team and received approximately $118 in salary and benefits during the year ended December 31, 2023.

Stakeholder Impact

  • Shareholders may be concerned about the material weakness in internal controls and the impairment of goodwill.
  • Employees may be affected by the company's financial performance and any potential restructuring.
  • Customers may be impacted by any changes in the company's operations or product offerings.
  • Creditors may be concerned about the company's ability to repay its debts given the financial losses.

Next Steps

  • The company will continue to enhance the precision of its internal controls, including involving third-party valuation specialists.
  • Management will operate the revised control procedures for a sufficient period of time to provide reasonable assurance as to their effectiveness.
  • The company will continue to monitor the performance of its various segments and make adjustments as necessary.

Key Dates

DateDescription
December 31, 2023End of the fiscal year for which the report is filed.
March 13, 2024Date of the original 10-K filing.
April 26, 2024Date of Amendment No. 1 to the original 10-K filing.
June 24, 2024Date of this Amendment No. 2 filing.

Keywords

financial reporting, internal control, goodwill, intangible assets, impairment, cannabis, financial statements, material weakness, valuation, restatement

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.